Researchers at the Mayo Clinic have developed an artificial intelligence tool designed to assist dermatologists in evaluating skin lesions. According to a study published in Mayo Clinic Proceedings, the technology provides clinicians with additional data to help determine whether a lesion requires an immediate biopsy or if it is safe to monitor over time.
Supporting Clinical Judgment
The AI tool functions as a decision-support system, offering objective insights that complement a dermatologist's visual assessment. By analyzing lesion characteristics, the tool aims to reduce diagnostic uncertainty, potentially helping clinicians avoid unnecessary procedures while ensuring that suspicious growths are identified promptly.
This development represents a growing trend in medical technology, where AI is integrated into clinical workflows to improve diagnostic accuracy and patient outcomes. As dermatologists face the challenge of distinguishing between benign and malignant skin conditions, such tools may become essential in streamlining patient care and optimizing biopsy rates.
